Immunitybio Inc (IBRX) is around the top of the Biotechnology industry according to InvestorsObserver. IBRX received an overall rating of 57, which means that it scores higher than 57 percent of all stocks. Immunitybio Inc also achieved a score of 74 in the Biotechnology industry, putting it above 74 percent of Biotechnology stocks. Biotechnology is ranked 53 out of the 148 industries.
IBRX has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on IBRX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Immunitybio Inc Stock Today?
Immunitybio Inc (IBRX) stock is trading at $3.95 as of 11:50 AM on Wednesday, Nov 22, a gain of $0.20, or 5.48% from the previous closing price of $3.74. The stock has traded between $3.82 and $4.11 so far today. Volume today is low. So far 1,713,896 shares have traded compared to average volume of 8,098,604 shares.
Click Here to get the full Stock Report for Immunitybio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
